Cue Biopharma CEO Daniel Passeri's 2020 pay jumps 387% to $5.8M
Cue Biopharma reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
Cue Biopharma reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, three executives at Cue Biopharma received on average a compensation package of $3.4M, a 98% increase compared to previous year.
Average pay of disclosed executives at Cue Biopharma
Daniel R. Passeri, Chief Executive Officer, received $5.8M in total, which increased by 387% compared to 2019. 49% of Passeri's compensation, or $2.8M, was in stock awards. Passeri also received $245K in bonus, $2.2M in option awards, $501K in salary, as well as $5.8K in other compensation.
Kerri-Ann Millar, Chief Financial Officer, received a compensation package of $2.2M, which increased by 390% compared to previous year. 63% of the compensation package, or $1.4M, was in option awards.
Anish Suri, Chief Scientific Officer, earned $2.1M in 2020, a 53% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2021.